# Revacept in Symptomatic Carotid Stenosis

Study · id `cardio:ct-nct01645306` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01645306](<https://clinicaltrials.gov/study/NCT01645306>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01645306

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Coronary and vascular disease; Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

## Technical summary

Registry record NCT01645306. Randomized; quadruple masking; primary purpose treatment. Start 2013-03-08 (actual); primary completion 2018-10-05 (actual). Results posted on 2021-01-28.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 158 participants (enrolled count; ClinicalTrials.gov record NCT01645306, source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)
- Started: 2013-03-08 (actual) (ClinicalTrials.gov record NCT01645306, source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)
- Primary completion: 2018-10-05 (actual) (ClinicalTrials.gov record NCT01645306, source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)
- Completion: 2019-09-23 (actual) (ClinicalTrials.gov record NCT01645306, source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)
- Results first posted: 2021-01-28 (ClinicalTrials.gov record NCT01645306, source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)
- Countries: Germany; United Kingdom (ClinicalTrials.gov record NCT01645306, source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01645306-2021-01-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Revacept in Symptomatic Carotid Stenosis
- Acronym: RevaceptCS02
- Condition: Carotid Stenosis
- Condition: Atherosclerosis
- Condition: Stroke
- Condition: Transient-ischaemic Attack
- Condition: TIA
- Condition: Amaurosis Fugax
- Intervention (Drug): Revacept
- Intervention (Drug): Placebo
- Lead sponsor: AdvanceCor GmbH
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II Trial (`cardio:pubmed-35695006`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0e7cb4158c18235280d6f66cb4c9dfb3541987a5703c4a95cb59eb48d952c79f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
